Pandemic-related disruptions in cancer screening showed an uneven recovery in 2023, data from the National Health Interview ...

Researchers examined screening rates for three kinds of cancer before, during, and after the COVID-19 pandemic.

Despite a proven survival benefit, the addition of pembrolizumab (Keytruda) to chemoradiotherapy for newly diagnosed locally ...

A new government report says that rates for precancerous lesions decreased about 80% among younger women who were screened ...

Bandi and her team found that past-year cervical cancer screenings in 2023 remained at 14%, which is below pre-pandemic ...

Cancer death rates continue to decline, in part to earlier detection for certain types of the disease. But, screenings for ...

A recent CDC report further demonstrates the effectiveness of the HPV vaccine against cervical cancer. HPV is a sexually ...

Cervical cancer incidence is rising, with rural and minoritized populations experiencing worse outcomes due to suboptimal ...

After a long decline, cervical cancer rates are rising in rural counties, increasing a gap with urban counties, a new study ...

Cervical cancer deaths have dropped due to better screening, but fewer women are keeping up with tests. An AXA Health ...

Chemoradiation improves survival in cervical cancer patients, but benefits may decline after age 80, according to a study ...